相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of Mycobacterium avium Infection
Jean-Philippe Lanoix et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
Charles L. Daley et al.
CLINICAL INFECTIOUS DISEASES (2020)
Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease
Bo-Guen Kim et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
Nakwon Kwak et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Epidemiology of Nontuberculous Mycobacterial Infection, South Korea, 2007-2016
Hyewon Lee et al.
EMERGING INFECTIOUS DISEASES (2019)
In vitro activity of aminoglycosides, clofazimine, D-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates
Chen-Cheng Huang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2018)
Clofazimine for Treatment of Extensively Drug-Resistant Pulmonary Tuberculosis in China
Qingfeng Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China
Jingjing Luo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis
Matthew Schwartz et al.
MICROBIAL DRUG RESISTANCE (2018)
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
Charles S. Haworth et al.
THORAX (2017)
Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease
Hayoung Choi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection
Stacey L. Martiniano et al.
CHEST (2017)
Treatment Outcomes of Mycobacterium avium Complex Lung Disease: A Systematic Review and Meta-analysis
Nakwon Kwak et al.
CLINICAL INFECTIOUS DISEASES (2017)
Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease
Bumhee Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease
Seong Mi Moon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin
Julie Jarand et al.
CHEST (2016)
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases
Kozo Morimoto et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria A Review
D. Rebecca Prevots et al.
CLINICS IN CHEST MEDICINE (2015)
The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea
Song Yee Kim et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis
Shuo Zhang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex
S. Singh et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients
K. J. M. Aung et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples An NTM-NET collaborative study
Wouter Hoefsloot et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
In Vitro Synergy between Clofazimine and Amikacin in Treatment of Nontuberculous Mycobacterial Disease
Jakko van Ingen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Clofazimine: current status and future prospects
Moloko C. Cholo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Mycobacterium abscessus: a new antibiotic nightmare
Rachid Nessar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria
Gwan-Han Shen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine
SK Field et al.
CHEST (2003)
分享论文
